Phoenix Holdings Ltd. Protalix Bio Therapeutics, Inc. Transaction History

Phoenix Holdings Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.56 $248,995 - $380,816	-244,113 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$3.58 - $6.45 $873,924 - $1.57 Million	244,113 New	244,113 $1.09 Million
Q4 2020 Feb 11, 2021	SELL	$3.15 - $3.98 $643,718 - $813,332	-204,355 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$3.37 - $3.93 $53,984 - $62,954	16,019 Added 8.51%	204,355 $751,000
Q2 2020 Aug 10, 2020	BUY	$2.19 - $4.5 $412,455 - $847,512	188,336 New	188,336 $681,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Phoenix Holdings Ltd., based on Form 13F filings with the SEC.

Stay updated on Phoenix Holdings Ltd. with notifications on news.